Cancer
ranks as a leading cause of death in every country of the
world. However, if they are discovered early, a lot of cancers can
be prevented or cured. Discovering and monitoring cancer markers are
the main methods for early diagnosis of cancer. To date, many fluorescent
probes designed and used for early cancer diagnosis can only react
with a single marker, which always causes insufficient accuracy in
complex systems. Herein, a novel near-infrared (NIR) fluorescent probe
(CyO-DNP) for the sequential detection of H2S and H+ is synthesized. In this probe, a heptamethine dye is selected
as the fluorophore and a 2,4-dinitrophenyl (DNP) ether is chosen as
recognition group. In the presence of H2S, CyO-DNP is transformed
into CyO, which exhibits an intense fluorescence at 663 nm. Then,
H+ induces the protonation of CyO to obtain CyOH, and the
final fluorescence emission at 793 nm significantly enhances. Owing
to the low cytotoxicity and the NIR fluorescence emission, CyO-DNP
can sequentially monitor endogenous H2S and H+ in cancer cells and image exogenous and endogenous H2S and H+ in mice. It is worth mentioning that CyO-DNP
can effectively avoid the false positive signal caused by the liver
and kidney and discriminate normal mice and tumor mice accurately.
For all we know, CyO-DNP is the first fluorescent probe for early
accurate diagnosis of cancer by sequentially detecting H2S and H+.